A new, compact synthesizer of PET radiotracers -- about a third the size of systems currently available -- is poised to enter the U.S. market later this year. Hear an interview with its inventor, Maxim Kiselev, Ph.D., vice president of R&D for IBA Molecular.
A new, compact synthesizer of PET radiotracers - about a third the size of systems currently available - is poised to enter the U.S. market later this year. Synthera, developed by IBA (Ion Beam Applications) Molecular and priced at about $96,000, was unveiled at the Society of Nuclear Medicine meeting June 3 to 7 in San Diego. Its core component, the ejectable Integrated Fluidic Processor, makes it a true multirun system capable of producing various radiotracers, including FDG, according to its inventor, Maxim Kiselev, Ph.D., vice president of R&D for IBA Molecular. (hear a two-minute interview with Kiselev from the SNM exhibit floor)
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.